You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Biologically Active
Featured Product
Search results for: 'active'
RecombinantIHH,Human [orb1494835]> 95% as analyzed by SDS-PAGE.
20 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 50 μg, 10 μg> 98% as analyzed by SDS-PAGE.
7.6 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 1 mg, 10 μg> 98% as analyzed by SDS-PAGE.
8.2 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg> 95% as analyzed by SDS-PAGE and HPLC.
7.8 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg- RecombinantMCP-1/CCL2,Rat [orb1494632]
> 98% as analyzed by SDS-PAGE.
10~15 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg > 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg, 1 mg> 98% as analyzed by SDS-PAGE.
8.3 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg> 98% as analyzed by SDS-PAGE.
8.7 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg, 1 mg> 95% as analyzed by SDS-PAGE and HPLC.
42 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg>95% by SDS-PAGE and HPLC analyses.
Approximately 17.5 kDa. The recombinant protein preparation is a mixture of a 158 amino acid residue form containing an N-terminal methionine and a 157 amino acid residue form with the sequence of mature human TNF-α.
Escherichia coli.
10 μg, 50 μg, 1 mg